YMAB - Y mAbs Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Y mAbs Therapeutics's activity chart (see below) currently has 73 price targets and 66 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31% with an average time for these price targets to be met of 82 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 06-Aug-2025. First documented stock forecast 16-Oct-2018.

Best performing analysts who are covering YMAB - Y mAbs Therapeutics:

Peter Lawson Etzer Darout Ying Huang Robert Burns Tessa Romero Alec Stranahan

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jan-2020

$8.6

$-0.01 (-0.12%)

$11

Sell Since 10-May-2023

$8.6

$-0.01 (-0.12%)

Buy Since 28-Jun-2024

$8.6

$-0.01 (-0.12%)

$14

Buy Since 18-Nov-2024

$15

$6.39 (74.22%)

$20

Show more analysts

Please expand the browser size to see the chart

What is YMAB (Y mAbs Therapeutics) average time for price targets to be met?

On average it took 82 days on average for the stock forecasts to be realized with a an average price target met ratio 31

Which analyst has the current highest performing score on YMAB (Y mAbs Therapeutics) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on YMAB (Y mAbs Therapeutics)?

Peter Lawson works at BARCLAYS and has 6 price targets and 5 ratings on YMAB

Which analyst is the currently most bullish on YMAB (Y mAbs Therapeutics)?

Peter Lawson with highest potential upside - $56.39

Which analyst is the currently most reserved on YMAB (Y mAbs Therapeutics)?

Alec Stranahan with lowest potential downside - -$5.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?